This image is a representation. Your design will be featured in the final product.

ORALHERP : treatment for labial herpes

ORALHERP is a filmogen liquid bandage designed to treat labial herpes lesions. It provides a protective barrier, cleans the affected area through osmotic action, and promotes cellular repair and growth. Clinical trials have shown significant reduction in lesion size and virus-infected cells within a week, along with clear improvement in symptoms such as itching, burning, and pain.  

Clinical trial

Randomized, double-blind, placebo-controlled trial


This product is intended for adult use


Treatment for labial herpes


ORALHERP is a filmogen liquid bandage specifically designed for the treatment of labial herpes lesions. This product targets pro-inflammatory proteins, contaminants, and impurities, providing a comprehensive approach to lesion treatment.

Mode of action

ORALHERP operates in three stages to aid in the healing of labial herpes lesions:


Protective Barrier Effect:

The product forms a protective barrier over the lesion, preventing the worsening of the lesion and the spread of the virus. 

Osmotic and Cleaning Effect:

ORALHERP aids in cleaning the lesion by removing impurities and contaminants, providing a clean environment for healing.


Cellular Repair and Growth Effect:

The product promotes the repair and growth of cells in the affected area, accelerating the healing process.

Clinical Trial

A randomized, double-blind, placebo-controlled clinical trial conducted over a period of 2 weeks with 60 patients showed significant results.


Key Findings

The main results of the study were as follows:

  • The size of the lesion was significantly reduced within 7 days.
  • The intensity of pain was significantly reduced within 21 days.
  • Irritation was notably reduced within 14 days.
  • Rectal bleeding was significantly reduced within 21 days.
  • Lesion hydration improved within 14 days.
  • Discomfort during defecation was reduced within 14 days.

See full publication (PDF)



Size of the lesion

• 55,3 % reduction in size of the lesion within 4 days.
• 87,4 % reduction in size of the lesion within 7 days.


Amount of virus

• 75 % reduction in amount of virus-infected cells within 4 days.
• 90 % reduction in amount of virus-infected cells within 7 days.
• Growth completely stopped between 7 and 14 days.



• Clear improvement (on itching, burning and pain) was seen from day 4 onwards, and most patients had only minor topical irritation on day 7.
• Lesion tenderness, soreness, swelling around the lesion, and blister oozing which diminished progressively within a week and disappeared in most patients during the second week of treatment.

Product Details

  • Indication: Filmogen liquid bandage for the treatment of labial herpes lesions.
  • Composition: Filmogenic glycerol, xanthan gum, honey, water, association of Camellia sinensis, Vitis vinifera, and Sambucus nigra.
  • Presentation: Tube 6ml.
  • Class: Current certification: MDD Class IIa | Certification in progress: MDR Class IIa.
  • Direction: Apply to wounds, 2-3 times a day.
  • Precautions: The product is intended for topical use only (labial surface) and should not be swallowed. Keep out of reach and sight of children.
  • Age: 18+.
  • Storage conditions: Below 25°C.
  • Legal manufacturer: VITROBIO (France).
  • Product code: HL.